Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Impact of tumor size on survival outcome in metastatic renal cell carcinoma patients (mRCC) treated with targeted therapy. Xie, W., DiNatale, R., Hakimi, A., Donskov, F., Porta, C., Reaume, M., Basappa, N. S., Hansen, A., Rini, B. I., Beuselinck, B., Bjarnason, G. A., Srinivas, S., Brugarolas, J., Rha, S., Wood, L., Lalani, A. A., Bosse, D., Duquette, A., Heng, D., Choueiri, T. K. AMER SOC CLINICAL ONCOLOGY. 2018
View details for DOI 10.1200/JCO.2018.36.6_suppl.667
View details for Web of Science ID 000436179500661